ProCE Banner Activity

Mechanisms of Action: SGLT2 Inhibitors, GLP-1 Receptor Agonists, and GIP/GLP-1 Receptor Coagonists

Video

Watch this short video describing the mechanisms of action of SGLT2 inhibitors, GLP-1 receptor agonists, and GIP/GLP-1 coagonists in type 2 diabetes and obesity.

Released: November 07, 2023

Share

Faculty

Carol Hatch Wysham

Carol Hatch Wysham, MD

Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Provided by

Provided by Clinical Care Options, LLC in partnership with Endocrine Society

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

Endocrine Society

ProCE Banner

Faculty Disclosure

Primary Author

Carol Hatch Wysham, MD

Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Carol Hatch Wysham, MD: consultant/advisor/speaker: Abbott, Biomea. researcher: Corcept, Bayer, Eli Lilly, Novo Nordisk, Regeneron, Vanda.